홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → HCID 178502143, 화합물

HRID 71954
인쇄

반응식

HRID 71954 반응식
[CH3:1][O:2][C:3](=[O:50])[NH:4][CH:5]([C:9]([N:11]1[CH:17]([C:18]2[NH:19][CH:20]=[C:21]([C:23]3[CH:32]=[CH:31][C:30]4[C:25](=[CH:26][CH:27]=[C:28]([C:33]5[CH:38]=[CH:37][C:36]([C:39](=[O:49])[CH2:40][NH:41]C(OC(C)(C)C)=O)=[CH:35][CH:34]=5)[CH:29]=4)[CH:24]=3)[N:22]=2)[CH2:16][C:13]2([CH2:15][CH2:14]2)[CH2:12]1)=[O:10])[CH:6]([CH3:8])[CH3:7].Cl.CCN(C(C)C)C(C)C.[C:61]([N:68]1[CH2:72][CH2:71][S:70][C@H:69]1[C:73]([OH:75])=O)([O:63][C:64]([CH3:67])([CH3:66])[CH3:65])=[O:62].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>C(Cl)Cl.O1CCOCC1.CN(C=O)C.CCOC(C)=O>[C:64]([O:63][C:61]([N:68]1[CH2:72][CH2:71][S:70][CH:69]1[C:73](=[O:75])[NH:41][CH2:40][C:39]([C:36]1[CH:37]=[CH:38][C:33]([C:28]2[CH:27]=[CH:26][C:25]3[C:30](=[CH:31][CH:32]=[C:23]([C:21]4[N:22]=[C:18]([CH:17]5[CH2:16][C:13]6([CH2:15][CH2:14]6)[CH2:12][N:11]5[C:9](=[O:10])[CH:5]([NH:4][C:3]([O:2][CH3:1])=[O:50])[CH:6]([CH3:7])[CH3:8])[NH:19][CH:20]=4)[CH:24]=3)[CH:29]=2)=[CH:34][CH:35]=1)=[O:49])=[O:62])([CH3:65])([CH3:66])[CH3:67]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

10

반응물 5

HCID 313Hydrochloric AcidHCID 81531Diisopropylethylamine2회HCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 14775612(S)-3-Boc-thiazolidine-2-carboxylic acidHCID 178502144HCID 178502144, 화합물

생성물 1

HCID 178502143
HCID 178502143, 화합물
수율 102.4%

시약·촉매·용매 4

HCID 6228Dimethylformamide용매HCID 6344Dichloromethane용매HCID 8857Ethyl Acetate용매HCID 312751,4-Dioxane용매

실험 절차

{1-[6-(4-{6-[4-(2-tert-Butoxycarbonylamino-acetyl)-phenyl]-naphthalen-2-yl}-1H-imidazol-2-yl)-5-aza-spiro[2.4]heptane-5-carbonyl]-2-methyl-propyl}-carbamic acid methyl ester (395.0 mg, 0.581 mmol) was dissolved in DCM (4 mL) and HCl in dioxane (4M, 4 mL) was added and stirring at room temperature was continued. After 60 minutes, all volatiles were removed in vacuo. The crude material was used in the next step without further purification. The crude material was dissolved in DMF (2.0 mL) and DIEA (110.8 mg, 0.860 mmol) was added. A solution of N-Boc (S) thiazolidine-2-carboxylic acid (100.0 mg, 0.430 mmol), HATU (163.0 mg, 0.430 mmol) and DIEA (55.4 mg, 0.430 mmol) in DMF (1 mL) was added. The reaction was stirred at room temperature. After 20 minutes, the reaction was diluted with EtOAc and was washed with brine, sodium hydroxyl solution (1M), brine, and was dried over sodium sulfate. Filtration and removal of solvents in vacuo gave the crude material (350 mg), which was used in the next step without further purification.

후처리

  1. customall volatiles were removed in vacuo
  2. customThe crude material was used in the next step without further purification
  3. dissolutionThe crude material was dissolved in DMF (2.0 mL)
  4. stirringThe reaction was stirred at room temperature
  5. waitAfter 20 minutes
  6. washwas washed with brine, sodium hydroxyl solution (1M), brine
  7. dry with materialwas dried over sodium sulfate
  8. filtrationFiltration and removal of solvents in vacuo

출처 및 근거

ORD 기록
ord-714a2485a6c04a7183449dac2fde705b
출처 데이터셋
uspto-grants-2014_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08822430B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트